HTS heading 2933
31 exclusion requests, from 16 distinct filers, across the 2018–20 tranches.
31
requests filed
1
granted
3.2% (95% CI 0.6–16.2%, n=31)
grant rate, all filers
Cross-tranche — see caution below
3.2% (95% CI 0.6–16.2%, n=31)
excluding mass filers
31 requests
By tranche
| Tranche | Requests | Granted | Denied | Grant rate |
|---|---|---|---|---|
| List 3 | 14 | 0 | 14 | n too small |
| List 4A | 17 | 1 | 16 | n too small |
The cross-tranche rate above blends processes. Where this heading appears in more than one tranche, use the per-tranche rows. Where a rate reads “n too small”, fewer than 20 requests were decided and no rate is published for it.
Products filed under this heading
Product titles as they appear on the public docket, unedited. These are examples, not a complete list, and their presence here says nothing about their outcome.
- Bromine (Brominating) Tablets
- Hexaryl Biimidazoles
- 2-Isopropylimidazole
- 2-Propylimidazole
- BCDMH, a Water Treatment Biocide
- 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldi
- Benzoguanamine
- N-OCTYL PYRROLIDONE